Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer

/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers from...

Related Keywords

Brisbane ,Queensland ,Australia ,Denver ,Colorado ,United States ,Dal Porto ,Joseph Dal Porto ,Karim Dabbagh ,Johns Hopkins University ,Pfizer ,Arena Pharmaceuticals ,National Jewish Medical Research Center ,University Of Maryland School Medicine ,Preclinical Research ,Gilead Sciences Inc ,Chief Scientific ,Chief Executive Officer ,Second Genome ,Vice President ,Emerging Science ,Site Head ,Therapeutic Innovation ,West Coast ,Modus Biomedicine ,Roche Palo Alto ,Translational Clinical Biomarker ,Maryland School ,Gilead Sciences ,